Aleafia Health Inc.

Aleafia Health Inc.

ALEAF
Aleafia Health Inc.US flagOther OTC
0.00
USD
- -
- -
386.00Market Cap
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2019 Y
2020 Y
2023 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
0.11
- -
0.03
0.08
0.12
0.11
0.11
Basic EPS, GAAP
- -
-0.03
-0.09
-0.01
-0.08
-0.07
- -
-0.16
-0.24
-0.16
-0.18
-0.88
-0.09
-0.09
Free Cash Flow per Basic Share
- -
-0.05
-0.08
-0.02
- -
-0.02
-0.02
-0.07
-0.03
-0.19
-0.25
-0.09
-0.01
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.1
- -
- -
-0.08
-1.58
-1.58
0.17
0.06
0.65
1.41
0.21
-0.31
-0.31
Tangible Book Value per Share
- -
0.17
0.09
0.07
-0.01
-0.32
-0.33
0.21
-0.1
0.38
0.53
0.27
-0.02
-0.02
Basic Weighted Avg Shares
282
17
29
36
40
2
2
36
40
117
216
292
386
383
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
4
- -
3
16
36
43
43
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
-153.48
-61,473.42
-558.38
-146.68
-137.09
-40.93
-40.89
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
6
10
7
7
Net Income, GAAP
-1
-1
-3
-1
-3
- -
- -
-6
-10
-19
-40
-256
-35
-35
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
-153.67
-61,473.42
-556.55
-242.23
-704.36
-80.77
-80.86
Working Capital
- -
1
- -
- -
-1
-1
-1
7
-3
26
97
30
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
52
35
33
33
Total Equity
- -
3
3
3
-1
-1
-1
8
11
92
385
146
-9
-9
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-135.28
Return on Common Equity (%)
- -
- -
- -
-549.76
- -
- -
- -
- -
-218.39
-47.02
-20.84
-140.06
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'23
Sep'23
Mar'23
ST Debt
34
45
13
LT Borrowings
- -
- -
32
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
331
331
403
Market Capitalization
127
94
19

Working Capital

FRC

in mil. unless spec.
Jun'23
Sep'23
Mar'23
Total Current Assets
71
70
36
Cash, Cash Equivalents & STI
5
11
1
Accounts Receivable, Net
5
8
4
Inventories
41
44
19
Total Current Liabilities
50
66
36
Payables & Accruals
15
20
18
ST Debt
34
45
13
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-39.68%
187.5%
-106.11%
Free Cash Flow
866.45%
309.99%
-79.8%
Net Income, GAAP
6,037.61%
145.34%
-86.46%
Sales/Revenue/Turnover
- -
4,290.56%
18.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
11
11
9
12
43

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
0.02
-0.06
- -
-0.01
-0.09

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Patricia Symmes
Full Time Employees
158
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
85 Basaltic Road Concord ON Canada L4K 1G4
IPO Date
Mar 28, 2018
Business
Aleafia Health Inc. Aleafia Health Inc. (ALEAF) operates as a vertically integrated, federally licensed Canadian cannabis company focused on health and wellness products and services for medical and adult-use markets. The company produces a diverse portfolio of cannabis derivatives including oils, capsules, sprays, dried flower, pre-rolls, vapes, edibles, sublingual strips, topicals, concentrates, vape cartridges, bath bombs and soft gels; it offers these under brands such as Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips and Emblem. Aleafia Health maintains three licensed production facilities, including cultivation sites, an extraction and processing division, and a contract-manufacturing service; it also runs a national network of physician-led medical cannabis clinics and education centers providing patient consultations, telemedicine and treatment monitoring for conditions like chronic pain, anxiety and insomnia, with distribution to provincial regulators and retailers across Canada and select international markets including Europe and Australia. Founded in 2007 and headquartered in Concord, Ontario, the company serves recreational consumers and medical patients through scalable infrastructure in provinces such as Ontario, British Columbia and Manitoba. In January 2024, Red White & Bloom Brands Inc. completed the acquisition of Aleafia Health and certain subsidiaries through a court-approved transaction under the Companies’ Creditors Arrangement Act, transitioning the combined entity toward enhanced cross-border operations in Canada, the US and Europe with projected combined sales exceeding C$138 million; Beena Goldenberg serves as chief executive officer with her tenure extended through November 30, 2025 to support strategic initiatives.

Company News

APIChat
  • Red White & Bloom wraps up Aleafia acquisition

  • Aleafia Health Announces Successful Bids in Sale and Investment Solicitation Process

  • Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

  • Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

  • Maximizing Returns on a Budget: The Best Marijuana Penny Stocks Under $1

  • Cannabis weekly wrap: Red White & Bloom and Aleafia merge, Canopy Growth gets the boot and more

  • Cannabis companies Red White & Bloom and Aleafia Health to merge

  • Oh No, Canada

  • Aleafia Health Inc. (ALEAF) Q3 2023 Earnings Call Transcript

  • Aleafia Health to Announce Fiscal Year 2023 Third Quarter Results

  • Aleafia Health to Announce Fiscal Year 2023 Third Quarter Results

  • Aleafia Health Inc. (ALEAF) Q2 2023 Earnings Call Transcript

  • Aleafia Health Inc. (ALEAF) CEO Tricia Symmes on Q1 2023 Results - Earnings Call Transcript

  • Aleafia Health Inc. (ALEAF) CEO Tricia Symmes on Q5 2022 Results - Earnings Call Transcript

  • Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

  • Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

  • Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

  • Will Aleafia Reach Its Revenue Goals With Convertible Debt Being 'Pushed Back'? Analyst's Thoughts Post Q4 Earnings

  • Aleafia Health, Inc. (ALEAF) CEO Tricia Symmes on Q4 2021 Results - Earnings Call Transcript

  • Aleafia Health Q4 Revenue Declines 42.1% QoQ To $8.8M, Reports Narrower Net Loss